All of the following are cardioselective beta blockers EXCEPT:
**Core Concept**
Cardioselective beta blockers are a subclass of beta blockers that preferentially inhibit beta-1 adrenergic receptors in the heart, thereby reducing myocardial contractility and heart rate without significantly affecting beta-2 receptors in the lungs, liver, and skeletal muscle. This property makes them particularly useful in patients with obstructive airway disease, such as asthma or COPD.
**Why the Correct Answer is Right**
The correct answer is a non-cardioselective beta blocker, meaning it inhibits both beta-1 and beta-2 receptors. This results in a broader range of effects, including bronchoconstriction, which can exacerbate respiratory conditions. Atenolol (Option A) is a classic example of a cardioselective beta blocker, as it has a high affinity for beta-1 receptors. Other examples include metoprolol (Option B) and bisoprolol (Option C), which are all commonly used in the management of hypertension, angina, and heart failure.
**Why Each Wrong Option is Incorrect**
* **Option A:** Atenolol is a cardioselective beta blocker, making it an incorrect choice as the answer.
* **Option B:** Metoprolol is a cardioselective beta blocker, which is not in line with the question.
* **Option C:** Bisoprolol is also a cardioselective beta blocker, making it an incorrect choice.
**Clinical Pearl / High-Yield Fact**
When choosing a beta blocker, clinicians should consider the patient's respiratory status, as non-cardioselective beta blockers can cause bronchoconstriction, whereas cardioselective beta blockers are generally safer in patients with obstructive airway disease.
**Correct Answer: D. Non-selective beta blockers, such as propranolol, can cause bronchoconstriction and are not cardioselective.**